Inhibition of Kv2.1 voltage-dependent K+ channels in pancreatic beta-cells enhances glucose-dependent insulin secretion

J Biol Chem. 2002 Nov 22;277(47):44938-45. doi: 10.1074/jbc.M205532200. Epub 2002 Sep 20.

Abstract

Voltage-dependent (Kv) outward K(+) currents repolarize beta-cell action potentials during a glucose stimulus to limit Ca(2+) entry and insulin secretion. Dominant-negative "knockout" of Kv2 family channels enhances glucose-stimulated insulin secretion. Here we show that a putative Kv2.1 antagonist (C-1) stimulates insulin secretion from MIN6 insulinoma cells in a glucose- and dose-dependent manner while blocking voltage-dependent outward K(+) currents. C-1-blocked recombinant Kv2.1-mediated currents more specifically than currents mediated by Kv1, -3, and -4 family channels (Kv1.4, 3.1, 4.2). Additionally, C-1 had little effect on currents recorded from MIN6 cells expressing a dominant-negative Kv2.1 alpha-subunit. The insulinotropic effect of acute Kv2.1 inhibition resulted from enhanced membrane depolarization and augmented intracellular Ca(2+) responses to glucose. Immunohistochemical staining of mouse pancreas sections showed that expression of Kv2.1 correlated highly with insulin-containing beta-cells, consistent with the ability of C-1 to block voltage-dependent outward K(+) currents in isolated mouse beta-cells. Antagonism of Kv2.1 in an ex vivo perfused mouse pancreas model enhanced first- and second-phase insulin secretion, whereas glucagon secretion was unaffected. The present study demonstrates that Kv2.1 is an important component of beta-cell stimulus-secretion coupling, and a compound that enhances, but does not initiate, beta-cell electrical activity by acting on Kv2.1 would be a useful antidiabetic agent.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Calcium / metabolism
  • Calcium Channel Blockers / pharmacology
  • Delayed Rectifier Potassium Channels
  • Diazoxide / pharmacology
  • Female
  • Glucose / metabolism*
  • Humans
  • In Vitro Techniques
  • Insulin / metabolism*
  • Insulin Secretion
  • Insulinoma
  • Islets of Langerhans / cytology
  • Islets of Langerhans / drug effects*
  • Islets of Langerhans / metabolism*
  • Membrane Potentials / physiology
  • Mice
  • Pancreas / drug effects
  • Pancreas / metabolism
  • Patch-Clamp Techniques
  • Potassium Channel Blockers / pharmacology*
  • Potassium Channels / metabolism*
  • Potassium Channels, Voltage-Gated*
  • Recombinant Fusion Proteins / genetics
  • Recombinant Fusion Proteins / metabolism
  • Shab Potassium Channels
  • Tetraethylammonium / pharmacology
  • Tumor Cells, Cultured
  • Verapamil / pharmacology

Substances

  • Calcium Channel Blockers
  • Delayed Rectifier Potassium Channels
  • Insulin
  • KCNB1 protein, human
  • Kcnb1 protein, mouse
  • Potassium Channel Blockers
  • Potassium Channels
  • Potassium Channels, Voltage-Gated
  • Recombinant Fusion Proteins
  • Shab Potassium Channels
  • Tetraethylammonium
  • Verapamil
  • Glucose
  • Diazoxide
  • Calcium